Search
forCommunity 10 of 1000+
- Is there any role for topical DHT antagonists, or does a 5-AR inhibitor remove the need for them as therapy
- Similar 5ar inhibitors to fin?
- The fear mongering of 5AR inhibitors
- Guys if you can’t take 5AR inhibitors still get on treatment ASAP
- Why is the general consensus that if you can’t tolerate 5AR Inhibitors you’re “cooked”?
- Can gains from stemoxydine be permanently kept with 5AR inhibitors?
- Whoever had success with PYRILUTAMIDE, please give us hope outside of 5AR inhibitors.
- A better treatment would be a localized 5ar inhibitor that breaks down when it enters blood or leaves hair follicle
- Why does this industry still revolve around 5-AR inhibitors?
- Minoxidil is a 5ar inhibitor according to research
Research 10 of 1000+
- THE ROLE Of 5αR AND α1AR INHIBITORS IN MANAGEMENT OF BPH
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Table 2_Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques.xlsx
- Table 1_Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques.xlsx
- Computational drug discovery of potential 5α-reductase phytochemical inhibitors and hair growth promotion using in silico techniques
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Synthesis and Study of Some 17a-aza-D-homo Steroids as 5α-Reductase Inhibitors
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists